RESOLVE and SAVORY: subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic aortic valves

Summary

Better understanding of reduced leaflet motion in bioprosthetic aortic valves due to subclinical leaflet thrombosis is critical, and R. Makkar discusses two, single hospital registries which look at this phenomenon. Is there a difference between surgical and transcatheter aortic valves? Can DAPT strategies or the use of non-vitamin K antagonist anticoagulants (NOACs) play a role here? What is the effect of this phenomenon on clinical outcomes? Death rates? Strokes? Transient ischaemic attacks? Can these findings impact future guidelines concerning aortic valve replacement? Learn more…

This interview was recorded at the American College of Cardiology Scientific Sessions 2017 (ACC 17).